REPROCELL Corporate News (5)

REPROCELL Corporate News

The importance of internships for life science students

19 October 2018

ROSLINCT and REPROCELL awarded £1.2 million from Innovate UK for clinical-grade stem cell production

10 October 2018

REPROCELL announces the launch of a cutting-edge iPS cell genome editing service utilizing next-generation CRISPR/Cas9 technology: SNIPER

09 October 2018

How paid internships can benefit life science students

13 September 2018

Steminent Announces Japan partner REPROCELL has PMDA Approval of CTN for Phase II Trial of Stemchymal® SCA in the Treatment of Spinocerebellar Ataxia in Japan

01 August 2018

Human Tissue Experts REPROCELL Launch New Customized Primary Cell Isolation Services

21 June 2018

REPROCELL’s footprint extends to serve life sciences in India

13 June 2018

Acquisition of BioServe Biotechnologies India Pvt. Ltd.

26 April 2018

REPROCELL’s Dr David Bunton on April 2018 Trade Mission to China with Scottish First Minister Nicola Sturgeon

18 April 2018

Derek Mackay, SNP Cabinet Secretary for Finance and the Constitution, visits REPROCELL Europe, Glasgow

06 April 2018

REPROCELL’s David Bunton addresses the Scottish Parliament

21 March 2018

Patient-derived tumor organoids recapitulate clinical treatments

14 March 2018

REPROCELL’s Prof Stefan Przyborski to chair the SMi 2nd Annual Conference on 3D Cell Culture – London UK, 21-22 February 2018

24 January 2018

Formation of human tissue to improve drug testing and reduce animal research

19 January 2018

REPROCELL Launches New Global Website

15 January 2018

REPROCELL Announces Research Collaboration with Q Therapeutics and Dr Mahendra Rao

29 November 2017

REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services

08 November 2017

Article by Dr David Bunton (co-authored) in the European Pharmaceutical Review, Autumn 2017

27 September 2017

Nicola Sturgeon: interview at the official opening of REPROCELL’s Centre for Predictive Drug Discovery (YouTube video)

10 August 2017

Press Release: Nicola Sturgeon, First Minister of Scotland, opens REPROCELL European Headquarters in Glasgow

10 August 2017
 Previous 3 4 5 6 7 Next 

Stem cell and drug discovery scientists around the world are using REPROCELL’s services and products in their preclinical and clinical research.

 About REPROCELL

Subscribe to receive updates

Corporate news by tag

  1. 3D cell culture
  2. Clinical capabilities
  3. Drug discovery
  4. Genomic services
  5. Human tissue samples
  6. Human tissue testing
  7. Life sciences
  8. Precision medicine
  9. Product Catalog
  10. Stem cells

 Corporate news archive